Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost ...

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...

These five large-cap value dividend stocks look poised to provide some second-half gains with steady ultra-high-yield ...

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...